Post Doc Position available
Cancer Biotherapeutics, NICB, DCU have very recently been approached by a company willing to support an Irish Research Council Enterprise Partnership Scheme Postdoctoral Fellowship application.
The project will be based at the NICB, Dublin City University looking at novel combinations of tyrosine kinase inhbitors (TKIs) and antibody therapies in breast cancer models. The project will be cell culture-based and involve mechanistic and functional studies of the efficacy of TKIs in models of targeted therapy resistance.
If you are interested in applying for a 24-month IRC EPS postdoctoral fellowship and have not been employed as a postdoctoral researcher for more than 5 years as of the 31st July 2017, please send a CV and introductory email to email@example.com before the 29th May 2017.
The deadline for the Fellowship application is the 8th June 2017. If the application is successful, the Fellowship would commence on 1st January 2018.